Trials / Completed
CompletedNCT03898830
Eon™ FR Clinical Study Protocol 1064
A Prospective, Controlled, Standardized, Multi-center, Single-treatment, Single-arm Evaluation of the Eon™ FR 1064 nm Device to Reduce Abdominal Fat With a 12-week Observation Interval to Assess Safe Fat Reduction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Dominion Aesthetic Technologies, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the treatment of subjects with the eon™ FR 1064 nm device in a single session to thermally induce apoptosis in adipose tissue.
Detailed description
This study evaluates the treatment of subjects between 18-60 with the eon™ FR 1064 nm device in a single session to thermally induce apoptosis in adipose tissue in the abdomen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | eon™ FR 1064 nm device | The subject treatment area - abdomen, was treated with the 1064 nm wavelength laser. |
Timeline
- Start date
- 2018-12-08
- Primary completion
- 2019-03-22
- Completion
- 2019-03-22
- First posted
- 2019-04-02
- Last updated
- 2020-05-19
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03898830. Inclusion in this directory is not an endorsement.